Impact of National Institutes of Health Gastrointestinal PROMIS Measures in Clinical Practice: Results of a Multicenter Controlled Trial.
Impact of National Institutes of Health Gastrointestinal PROMIS Measures in Clinical Practice: Results of a Multicenter Controlled Trial.
复制标题
DOI：
10.1038/ajg.2016.305
复制
发表时间：
2016-11
影响因子：
9.8
通讯作者：
Spiegel, Brennan M. R.
中科院分区：
文献类型：
--
作者：
Almario, Christopher V.;Chey, William D.;Khanna, Dinesh;Mosadeghi, Sasan;Ahmed, Shahzad;Afghani, Elham;Whitman, Cynthia;Fuller, Garth;Reid, Mark;Bolus, Roger;Dennis, Buddy;Encarnacion, Rey;Martinez, Bibiana;Soares, Jennifer;Modi, Rushaba;Agarwal, Nikhil;Lee, Aaron;Kubomoto, Scott;Sharma, Gobind;Bolus, Sally;Spiegel, Brennan M. R.
The National Institutes of Health (NIH) created the Patient Reported Outcomes Measurement Information System (PROMIS®) to allow efficient, online measurement of patient-reported outcomes (PROs), but it remains untested whether PROMIS improves outcomes. Here, we aimed to compare the impact of gastrointestinal (GI) PROMIS measures vs. usual care on patient outcomes. We performed a pragmatic clinical trial with an off-on study design alternating weekly between intervention (GI PROMIS) and control arms at one Veterans Affairs (VA) and three university-affiliated specialty clinics. Adults with GI symptoms were eligible. Intervention patients completed GI PROMIS symptom questionnaires on an e-portal one week before their visit; PROs were available for review by patients and their providers prior to and during the clinic visit. Usual care patients were managed according to customary practices. Our primary outcome was patient satisfaction as determined by the Consumer Assessment of Healthcare Providers & Systems (CAHPS) questionnaire. Secondary outcomes included provider interpersonal skills (Doctors’ Interpersonal Skills Questionnaire [DISQ]) and shared decision-making (9-item Shared Decision Making Questionnaire [SDM-Q-9]). There were 217 and 154 patients in the GI PROMIS and control arms, respectively. Patient satisfaction was similar between groups (p>.05). Intervention patients had similar assessments of their providers’ interpersonal skills (DISQ 89.4±11.7 vs. 89.8±16.0, p=.79) and shared decision-making (SDM-Q-9 79.3±12.4 vs. 79.0±22.0, p=.85) vs. controls. This is the first controlled trial examining the impact of NIH PROMIS in clinical practice. One-time use of GI PROMIS did not improve patient satisfaction or assessment of provider interpersonal skills and shared decision-making. Future studies examining how to optimize PROs in clinical practice are encouraged before widespread adoption.
登录
查看更多内容
影响因子：
4.7
作者：
Nagaraja, Vivek;Hays, Ron D.;Khanna, Puja P.;Spiegel, Brennan M. R.;Chang, Lin;Melmed, Gil Y.;Bolus, Roger;Khanna, Dinesh
通讯作者：
Khanna, Dinesh
影响因子：
3.5
作者：
Lohr, Kathleen N.;Zebrack, Bradley J.
通讯作者：
Zebrack, Bradley J.
DOI：
10.1136/amiajnl.2010.006015
发表时间：
2011-05-01
影响因子：
6.4
作者：
Sarkar, Urmimala;Karter, Andrew J.;Schillinger, Dean
通讯作者：
Schillinger, Dean
影响因子：
5.4
作者：
Greenhalgh, J;Long, AF;Flynn, R
通讯作者：
Flynn, R
影响因子：
5.7
作者：
Goel, Mita Sanghavi;Brown, Tiffany L.;Baker, David W.
通讯作者：
Baker, David W.